{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:04:44Z","timestamp":1784603084939,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1053\/ajkd.2002.36853","type":"journal-article","created":{"date-parts":[[2002,12,2]],"date-time":"2002-12-02T13:45:51Z","timestamp":1038836751000},"page":"1111-1121","source":"Crossref","is-referenced-by-count":50,"title":["Iron sucrose: The oldest iron therapy becomes new"],"prefix":"10.1053","volume":"40","author":[{"given":"Jerry","family":"Yee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatole","family":"Besarab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2002.36853_bib1","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V94.6.1864","article-title":"Regulation of the erythropoietin gene","volume":"94","author":"Ebert","year":"1999","journal-title":"Blood"},{"key":"10.1053\/ajkd.2002.36853_bib2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1074\/jbc.M007597200","article-title":"A novel superoxide-producing NAD(P)H oxidase in kidney","volume":"276","author":"Shiose","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1053\/ajkd.2002.36853_bib3","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1073\/pnas.130135897","article-title":"Identification of Renox, an NADPH oxidase in kidney","volume":"97","author":"Geiszt","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/ajkd.2002.36853_bib4","first-page":"9","article-title":"Iron management during recombinant human erythropoietin therapy","volume":"14","author":"Van Wyck","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000168837","article-title":"Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients","volume":"15","author":"Tarng","year":"1995","journal-title":"Am J Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1525-139X.1995.tb00324.x","article-title":"The role of iron and other factors in patients unresponsive to erythropoietin therapy","volume":"8","author":"Kleiner","year":"1995","journal-title":"Semin Dial"},{"key":"10.1053\/ajkd.2002.36853_bib7","first-page":"607","article-title":"Poor response to erythropoietin: Practical guidelines on investigation and management","volume":"10","author":"Macdougall","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36853_bib8","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V1092029","article-title":"An indistinct balance: The safety and efficacy of parenteral iron therapy","volume":"10","author":"Besarab","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0272-6386(05)80001-0","article-title":"Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis","volume":"37","author":"Fishbane","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib10","first-page":"55","article-title":"Iron Therapy","author":"Danielson","year":"1996"},{"key":"10.1053\/ajkd.2002.36853_bib11","first-page":"417A","article-title":"IV iron agents donate iron to transferring in vitro","author":"Van Wyck","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib12","first-page":"615","article-title":"Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers","volume":"46","author":"Danielson","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1053\/ajkd.2002.36853_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1525-139X.1999.99030.x","article-title":"Comparative look at intravenous iron agents: Pharmacology, efficacy, and safety of iron dextran, iron saccharate, and ferric gluconate","volume":"12","author":"Sunder-Plassman","year":"1999","journal-title":"Semin Dial"},{"key":"10.1053\/ajkd.2002.36853_bib14","first-page":"475","article-title":"A pharmocokinetic and clinical evaluation of iron poly (sorbitol-gluconic acid) complex","volume":"2","author":"Campbell","year":"1980","journal-title":"Pharmatherapeutica"},{"key":"10.1053\/ajkd.2002.36853_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2141.1973.tb01777.x","article-title":"The metabolism of intravenously administered iron-dextran","volume":"25","author":"Kanakakorn","year":"1973","journal-title":"J Haematol"},{"key":"10.1053\/ajkd.2002.36853_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2141.1999.01170.x","article-title":"Kinetic analysis of 52Fe-labelled iron(III) hydroxide-sucrose complex following bolus administration using positron emission tomography","volume":"104","author":"Beshara","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/ajkd.2002.36853_bib17","first-page":"1439","article-title":"Structure histotoxicity relationship of parenteral iron preparations","volume":"42","author":"Geisser","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1053\/ajkd.2002.36853_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/ajkd.2001.21293","article-title":"Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial","volume":"37","author":"Charytan","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib19","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/clinchem\/45.6.898","article-title":"Comparison of methods used to measure serum iron in the presence of iron gluconate or iron dextran","volume":"45","author":"Seligman","year":"1999","journal-title":"Clin Chem"},{"key":"10.1053\/ajkd.2002.36853_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0272-6386(99)70103-4","article-title":"A study of parenteral iron regimens in hemodialysis patients","volume":"34","author":"Besarab","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(00)70294-0","article-title":"Parenteral iron use in the management of anemia in end-stage renal disease patients","volume":"35","author":"Bailie","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib22","first-page":"260A","article-title":"Can higher doses of IV iron be given as a bolus injection","volume":"12","author":"Chandler","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0272-6386(99)70184-8","article-title":"Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American clinical trial","volume":"33","author":"Nissenson","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib24","series-title":"Iron hydroxide sucrose complex in water (Venofer\u00ae) [package insert]","year":"2001"},{"key":"10.1053\/ajkd.2002.36853_bib25","series-title":"Sodium ferric gluconate complex in sucrose injection (Ferrlecit) [package insert]","year":"2001"},{"key":"10.1053\/ajkd.2002.36853_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0272-6386(96)90462-X","article-title":"Randomized crossover study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patients","volume":"28","author":"St Peter","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib27","first-page":"604","article-title":"Efficient anemia treatment with large intravenous iron doses","volume":"9","author":"Paschen","year":"1999","journal-title":"Geburtshilse frauenheilkunde"},{"key":"10.1053\/ajkd.2002.36853_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1537-2995.1999.39050465.x","article-title":"Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: A randomized, controlled study","volume":"39","author":"Weisbach","year":"1999","journal-title":"Transfusion"},{"key":"10.1053\/ajkd.2002.36853_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0272-6386(96)90546-6","article-title":"Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis","volume":"27","author":"Silverberg","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ki.1989.43","article-title":"Iron status in patients receiving erythropoietin for dialysis associated anemia","volume":"35","author":"Van Wyck","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36853_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000186721","article-title":"Intravenous Fe gluconate-Na for iron deficient patients on hemodialysis","volume":"60","author":"Pascual","year":"1992","journal-title":"Nephron"},{"key":"10.1053\/ajkd.2002.36853_bib32","first-page":"180","article-title":"Iron absorption and utilization in maintenance hemodialysis patients: Oral and intravenous routes","volume":"51","author":"Magana","year":"1984","journal-title":"Mt Sinai J Med"},{"key":"10.1053\/ajkd.2002.36853_bib33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/16.5.967","article-title":"A randomized study of oral vs intravenous supplementation in patients with progressive renal insufficiency treated with erythropoietin","volume":"16","author":"Stoves","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36853_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000188905","article-title":"Intravenous ferric saccharate as an iron supplement in dialysis patients","volume":"72","author":"Silverberg","year":"1996","journal-title":"Nephron"},{"key":"10.1053\/ajkd.2002.36853_bib35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1681\/ASN.V113530","article-title":"Optimization of epoetin therapy with intravenous iron in hemodialysis patients","volume":"11","author":"Besarab","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0272-6386(96)90463-1","article-title":"The safety of intravenous iron dextran in hemodialysis patients","volume":"28","author":"Fishbane","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib37","first-page":"330","article-title":"Lessons from NKF-DOQI: Iron management","volume":"20","author":"Van Wyck","year":"2000","journal-title":"Semin Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib38","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/ndt\/16.6.1239","article-title":"A randomized controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo","volume":"16","author":"Kosch","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36853_bib39","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1046\/j.1523-1755.2001.00077.x","article-title":"A randomized trial of iron deficiency testing strategies in hemodialysis patients","volume":"60","author":"Fishbane","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36853_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10715769800300011","article-title":"Oxidative stress in chronic renal failure","volume":"29","author":"Hasselwander","year":"1997","journal-title":"Free Radic Res"},{"key":"10.1053\/ajkd.2002.36853_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ki.1995.285","article-title":"Detection of oxidants in uremic plasma by electron spin resonance spectroscopy","volume":"48","author":"Roselaar","year":"1995","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36853_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/ajkd.2000.8276","article-title":"Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial","volume":"36","author":"Van Wyck","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib43","first-page":"35","article-title":"Dextran antibodies, complement conversion, and circulating immune complexes after intravenous iron dextran therapy in dialyzed patients","volume":"7","author":"Fleming","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36853_bib44","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0272-6386(99)70183-6","article-title":"Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans","volume":"33","author":"Faich","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib45","series-title":"Adverse Event Reporting System (AERS); Freedom of Information (FOI) Report","author":"Food and Drug Administration","year":"2001"},{"key":"10.1053\/ajkd.2002.36853_bib46","first-page":"333A","article-title":"Worldwide safety profile of iron sucrose injection (Venofer\u00ae): Analysis of 1,004,477 patients from 1992 to 2001","volume":"12","author":"Macdougall","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib47","first-page":"359A","article-title":"Safety of iron sucrose in the general hemodialysis population","volume":"12","author":"Lunde","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib48","first-page":"365A","article-title":"Administration of sodium ferric gluconate complex to iron-dextran-sensitive hemodialysis patients","volume":"12","author":"Warnock","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib49","first-page":"353A","article-title":"Iron sucrose may be safely administered to dialysis patients intolerant to other parenteral iron products","volume":"12","author":"Charytan","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib50","first-page":"225","article-title":"Superoxide production and human disease","author":"McCord","year":"1992"},{"key":"10.1053\/ajkd.2002.36853_bib51","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1016\/S0021-9258(19)83617-7","article-title":"Ferritin and superoxide-dependent lipid peroxidation","volume":"260","author":"Thomas","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1053\/ajkd.2002.36853_bib52","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1172\/JCI111364","article-title":"Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes","volume":"73","author":"Biemond","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2002.36853_bib53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1126\/science.185.4150.529","article-title":"Free radicals and inflammation: Protection of synovial fluid by superoxide dysmutase","volume":"185","author":"Cord","year":"1974","journal-title":"Science"},{"key":"10.1053\/ajkd.2002.36853_bib54","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/ndt\/12.11.2312","article-title":"Erythropoietin and oxidative stress in haemodialysis: Beneficial effects of vitamin E supplementation","volume":"12","author":"Cristol","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36853_bib55","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0891-5849(94)90035-3","article-title":"Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E, and iron status","volume":"16","author":"Peuchant","year":"1994","journal-title":"Free Radic Biol Med"},{"key":"10.1053\/ajkd.2002.36853_bib56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1047-2797(96)00112-3","article-title":"Iron status and the risk of cardiovascular disease","volume":"7","author":"Corti","year":"1997","journal-title":"Ann Epidemiol"},{"key":"10.1053\/ajkd.2002.36853_bib57","first-page":"190A","article-title":"Frequent IV iron dosing is associated with higher infectious deaths","volume":"8","author":"Collins","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.V83475","article-title":"Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other nontraditional cardiac risk factors","volume":"8","author":"Becker","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ndt\/5.2.130","article-title":"Iron overload in haemodialysis patients increases the risk for bacteremia: A prospective study","volume":"5","author":"Boelaert","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36853_bib60","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/ndt\/4.10.883","article-title":"Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections. Beneficial effects of desferrioxamine","volume":"4","author":"Tielmans","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36853_bib61","first-page":"227","article-title":"Impairment of phagocytic oxidative metabolism in hemodialysis patients with iron overload","volume":"25","author":"Flament","year":"1986","journal-title":"Clin Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib62","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1681\/ASN.V94655","article-title":"Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency","volume":"9","author":"Patruta","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the anemia of end stage renal disease with recombinant human erythropoietin: Results of a combined phase I and phase II clinical trial","volume":"316","author":"Eschbach","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.36853_bib64","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/ndt\/15.11.1827","article-title":"Catalytically active iron and bacterial growth in serum of haemodialysis patients after IV iron-saccharate administration","volume":"15","author":"Parkkinen","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36853_bib65","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2141.1971.tb02724.x","article-title":"The measurement of reticuloendothelial iron release using iron-dextran","volume":"21","author":"Beamish","year":"1971","journal-title":"Br J Haematol"},{"key":"10.1053\/ajkd.2002.36853_bib66","first-page":"988","article-title":"Intravenous iron sucrose: Establishing a safe dose","volume":"38","author":"Chandler","year":"2001","journal-title":"Am J Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib67","first-page":"379A","article-title":"Safety of sodium ferric gluconate complex in higher individual doses","volume":"12","author":"Folkert","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36853_bib68","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/S0272-6386(01)80154-2","article-title":"The incidence of side effects associated with high-dose ferric gluconate (Ferrlecit) in patients with severe chronic renal failure (CRF)","volume":"37","author":"Bastani","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib69","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(94)90797-8","article-title":"Intravenous iron-sucrose complex to reduce epoetin demand in dialysis patients","volume":"344","author":"Nyvad","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/ajkd.2002.36853_bib70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0272-6386(99)70104-6","article-title":"Indices of iron status in continuous ambulatory peritoneal dialysis patients","volume":"34","author":"Domrongkitchaiporn","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36853_bib71","first-page":"357A","article-title":"\u201cHigh dose\u201d sodium ferric gluconate (Ferrlecit\u00ae) is safe and effective in peritoneal dialysis patients","volume":"12","author":"Asuncion","year":"2001","journal-title":"J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860200238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860200238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T16:46:10Z","timestamp":1622479570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263860200238X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S027263860200238X"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2002.36853","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}